Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$0.53 - $0.93 $157,734 - $276,780
-297,613 Reduced 10.89%
2,435,240 $1.41 Million
Q4 2023

Feb 06, 2024

BUY
$0.63 - $1.14 $64,445 - $116,615
102,294 Added 3.89%
2,732,853 $2.27 Million
Q3 2023

Nov 08, 2023

BUY
$1.12 - $1.88 $229,130 - $384,612
204,581 Added 8.43%
2,630,559 $2.97 Million
Q2 2023

Aug 09, 2023

BUY
$1.31 - $2.04 $402,903 - $627,422
307,560 Added 14.52%
2,425,978 $3.88 Million
Q1 2023

May 11, 2023

BUY
$1.45 - $2.95 $21,077 - $42,881
14,536 Added 0.69%
2,118,418 $3.22 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $400,620 - $644,562
198,327 Added 10.41%
2,103,882 $5.05 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $165,621 - $265,333
84,501 Added 4.64%
1,905,555 $3.91 Million
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $167,323 - $339,794
128,710 Added 7.61%
1,821,054 $3.53 Million
Q1 2022

May 13, 2022

BUY
$2.35 - $3.47 $152,411 - $225,050
64,856 Added 3.99%
1,692,344 $4.16 Million
Q4 2021

Feb 11, 2022

BUY
$2.92 - $5.74 $420,301 - $826,209
143,939 Added 9.7%
1,627,488 $5.24 Million
Q3 2021

Nov 16, 2021

BUY
$4.98 - $6.63 $914,342 - $1.22 Million
183,603 Added 14.12%
1,483,549 $7.79 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $622,123 - $1.33 Million
243,017 Added 22.99%
1,299,946 $7.14 Million
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $53,942 - $105,278
20,053 Added 1.93%
1,056,929 $2.88 Million
Q4 2020

Feb 16, 2021

SELL
$3.17 - $4.49 $57,228 - $81,057
-18,053 Reduced 1.71%
1,036,876 $3.3 Million
Q3 2020

Nov 13, 2020

BUY
$2.98 - $5.2 $202,938 - $354,120
68,100 Added 6.9%
1,054,929 $4.22 Million
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $615,833 - $1.14 Million
268,923 Added 37.46%
986,829 $3.88 Million
Q1 2020

May 15, 2020

BUY
$1.92 - $4.39 $18,240 - $41,705
9,500 Added 1.34%
717,906 $1.76 Million
Q4 2019

Feb 07, 2020

SELL
$2.41 - $4.4 $127,840 - $233,402
-53,046 Reduced 6.97%
708,406 $2.88 Million
Q3 2019

Nov 08, 2019

BUY
$2.17 - $3.14 $94,167 - $136,260
43,395 Added 6.04%
761,452 $1.97 Million
Q2 2019

Aug 09, 2019

BUY
$2.53 - $3.04 $377,200 - $453,236
149,091 Added 26.2%
718,057 $2.16 Million
Q1 2019

May 14, 2019

BUY
$2.51 - $3.73 $189,615 - $281,779
75,544 Added 15.31%
568,966 $1.69 Million
Q4 2018

Feb 14, 2019

SELL
$1.59 - $2.66 $44,033 - $73,666
-27,694 Reduced 5.31%
493,422 $1.18 Million
Q3 2018

Nov 13, 2018

BUY
$1.59 - $2.42 $219,469 - $334,035
138,031 Added 36.03%
521,116 $1.12 Million
Q2 2018

Aug 08, 2018

BUY
$2.26 - $4.65 $76,986 - $158,402
34,065 Added 9.76%
383,085 $870,000
Q1 2018

May 07, 2018

BUY
$3.51 - $6.04 $114,443 - $196,934
32,605 Added 10.3%
349,020 $1.64 Million
Q4 2017

Jan 17, 2018

BUY
$3.26 - $4.78 $112,143 - $164,432
34,400 Added 12.2%
316,415 $1.03 Million
Q3 2017

Nov 13, 2017

BUY
$3.48 - $4.44 $981,412 - $1.25 Million
282,015
282,015 $1.24 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.